A case of severe cutaneous adverse reaction following administration of the Janssen Ad26.COV2.S COVID-19 vaccine
Gespeichert in:
| Veröffentlicht in: | JAAD Case Reports Jg. 13; S. 134 - 137 |
|---|---|
| Hauptverfasser: | , , , , |
| Format: | Journal Article |
| Sprache: | Englisch |
| Veröffentlicht: |
United States
Elsevier Inc
01.07.2021
Elsevier |
| Schlagworte: | |
| ISSN: | 2352-5126, 2352-5126 |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| Author | Mochel, Mark C. Nutan, Fnu Malachowski, Stephen J. Nichols, Cameron S. Lospinoso, Kristen |
|---|---|
| Author_xml | – sequence: 1 givenname: Kristen surname: Lospinoso fullname: Lospinoso, Kristen organization: Deparment of Dermatology, Virginia Commonwealth University Health System, Richmond, Virginia – sequence: 2 givenname: Cameron S. surname: Nichols fullname: Nichols, Cameron S. organization: Deparment of Dermatology, Virginia Commonwealth University Health System, Richmond, Virginia – sequence: 3 givenname: Stephen J. surname: Malachowski fullname: Malachowski, Stephen J. email: Stephen.Malachowski@vcuhealth.org organization: Deparment of Dermatology, Virginia Commonwealth University Health System, Richmond, Virginia – sequence: 4 givenname: Mark C. surname: Mochel fullname: Mochel, Mark C. organization: Deparment of Dermatology, Virginia Commonwealth University Health System, Richmond, Virginia – sequence: 5 givenname: Fnu surname: Nutan fullname: Nutan, Fnu organization: Deparment of Dermatology, Virginia Commonwealth University Health System, Richmond, Virginia |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/34056055$$D View this record in MEDLINE/PubMed |
| BookMark | eNqFkk1v00AQhi1UREvpH-CAfOQSM_sZG6FKUaAQVKmHAtfVZj1O1zi76a4T1H_fddyithLlNKudeZ_RzLyvswPnHWbZWwIFASI_tEVbm1BQoKQAUQCBF9kRZYJOBKHy4MH7MDuJsQUAIviUTcmr7JBxEBKEOMo2s9zoiLlv8og7DJibba8d-m3MdZ0-Ui6gNr31Lm981_k_1q1Sam2djX3Q-0RS91eYf9cuRnT5rKaymF_8osVlnsLi84RU-U4bYx2-yV42uot4chePs59nX37Mv03OL74u5rPziRGcwqRkkkHdSKymwBBEA41ghsgaOaW8YnXFtaEEJS-FZLrWVE81qfiyZBzFsmHH2WLk1l63ahPsWocb5bVV-w8fVkqH3poOVUMTgZYGTEk5yFJLrgWttGYEGypMYp2OrM12ucbaoEuDd4-gjzPOXqmV36mS8IrIMgHe3wGCv95i7NXaRoNdN25aUcEEgakkVSp997DX3yb3J0sF5Vhggo8xYKOM7fdnSK1tpwiowSCqVYNB1GAQBUIlgyQpfSK9pz8r-jSKMF1rZzGoaCw6g7UNaPq0Tvu8_PSJ3HTJOkZ3v_EGY-u3wSUfKKIiVaAuB9sOrqUEgHE5zPvx34D_db8Ff9X6dA |
| CitedBy_id | crossref_primary_10_3390_jcm10225344 crossref_primary_10_1002_jvc2_56 crossref_primary_10_3390_vaccines9090944 crossref_primary_10_1007_s00403_024_03389_z crossref_primary_10_3390_biomedicines10050999 crossref_primary_10_1111_myc_13506 crossref_primary_10_7759_cureus_31310 crossref_primary_10_1007_s13671_022_00374_5 crossref_primary_10_1007_s10278_023_00795_z crossref_primary_10_1016_j_jaip_2023_04_045 crossref_primary_10_1016_j_jdcr_2021_11_028 crossref_primary_10_3389_fphar_2022_921760 crossref_primary_10_1111_cup_14371 crossref_primary_10_1016_j_jdin_2022_01_011 crossref_primary_10_1111_jocd_15224 crossref_primary_10_4103_ijd_ijd_670_21 crossref_primary_10_1097_DAD_0000000000002320 crossref_primary_10_7759_cureus_24126 crossref_primary_10_1111_ddg_15477 crossref_primary_10_1111_1346_8138_16347 crossref_primary_10_1007_s40278_021_98950_4 crossref_primary_10_1111_jdv_18294 crossref_primary_10_1016_j_clindermatol_2024_12_021 crossref_primary_10_1016_j_jdcr_2021_08_037 crossref_primary_10_1111_ddg_15477_g crossref_primary_10_1016_j_jmii_2022_09_004 crossref_primary_10_1111_1346_8138_16541 crossref_primary_10_1111_jdv_18777 crossref_primary_10_1016_j_jaip_2025_02_006 crossref_primary_10_1111_jdv_17744 crossref_primary_10_1016_j_clindermatol_2022_02_018 crossref_primary_10_1016_j_jaip_2023_06_057 crossref_primary_10_1016_j_jaip_2022_04_035 crossref_primary_10_3390_biomedicines9111740 crossref_primary_10_1111_ijd_16063 crossref_primary_10_1111_dth_15391 crossref_primary_10_1146_annurev_publhealth_071723_102841 crossref_primary_10_3390_vaccines11081298 crossref_primary_10_3390_jcm11020397 crossref_primary_10_5021_ad_21_138 crossref_primary_10_2340_actadv_v101_443 |
| Cites_doi | 10.1001/jama.2021.2927 10.5070/D3271052044 10.1016/j.clindermatol.2014.12.009 10.1016/j.jdcr.2021.02.014 10.1111/bcp.14112 10.1126/science.370.6520.1022 10.1016/S0140-6736(16)30378-6 10.4168/aair.2014.6.3.216 10.1016/j.jaad.2015.07.017 |
| ContentType | Journal Article |
| Copyright | 2021 American Academy of Dermatology, Inc. American Academy of Dermatology, Inc. 2021 by the American Academy of Dermatology, Inc. Published by Elsevier, Inc. 2021 American Academy of Dermatology, Inc. |
| Copyright_xml | – notice: 2021 American Academy of Dermatology, Inc. – notice: American Academy of Dermatology, Inc. – notice: 2021 by the American Academy of Dermatology, Inc. Published by Elsevier, Inc. 2021 American Academy of Dermatology, Inc. |
| DBID | 6I. AAFTH AAYXX CITATION NPM 7X8 5PM DOA |
| DOI | 10.1016/j.jdcr.2021.05.010 |
| DatabaseName | ScienceDirect Open Access Titles Elsevier:ScienceDirect:Open Access CrossRef PubMed MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
| DatabaseTitle | CrossRef PubMed MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 2352-5126 |
| EndPage | 137 |
| ExternalDocumentID | oai_doaj_org_article_f263a28c0c824068a64a529aa31ef25c PMC8149168 34056055 10_1016_j_jdcr_2021_05_010 S2352512621003465 1_s2_0_S2352512621003465 |
| Genre | Case Reports |
| GroupedDBID | .1- .FO 0R~ 1P~ 4.4 457 53G 5VS AAEDT AAEDW AAIKJ AALRI AAXUO AAYWO ABMAC ACGFS ACVFH ADBBV ADCNI ADEZE ADVLN AEUPX AEXQZ AFJKZ AFPUW AFRHN AFTJW AGHFR AIGII AITUG AJUYK AKBMS AKRWK AKYEP ALMA_UNASSIGNED_HOLDINGS AMRAJ AOIJS APXCP BAWUL BCNDV EBS EJD FDB GROUPED_DOAJ HYE IPNFZ IXB KQ8 M41 M~E O9- OK1 RIG ROL RPM SSZ Z5R 0SF 6I. AACTN AAFTH AFCTW NCXOZ AAYXX CITATION NPM 7X8 5PM |
| ID | FETCH-LOGICAL-c5420-83630df6e9703e05f0f53c16de422493d94ac21e648563ada2a7a194b834e5bf3 |
| IEDL.DBID | DOA |
| ISSN | 2352-5126 |
| IngestDate | Fri Oct 03 12:52:39 EDT 2025 Thu Aug 21 18:21:17 EDT 2025 Thu Sep 04 19:35:18 EDT 2025 Thu Jan 02 22:53:22 EST 2025 Wed Nov 12 18:30:53 EST 2025 Tue Nov 18 22:22:11 EST 2025 Tue May 16 22:23:25 EDT 2023 Tue Feb 25 20:12:40 EST 2025 Tue Aug 26 16:39:37 EDT 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Keywords | COVID-19 vaccine DRESS severe adverse cutaneous reaction SCAR AGEP severe cutaneous adverse reaction drug reaction with eosinophilia and systemic symptoms acute generalized exanthematous pustulosis DRESS, drug reaction with eosinophilia and systemic symptoms AGEP, acute generalized exanthematous pustulosis SCAR, severe cutaneous adverse reaction |
| Language | English |
| License | This is an open access article under the CC BY-NC-ND license. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c5420-83630df6e9703e05f0f53c16de422493d94ac21e648563ada2a7a194b834e5bf3 |
| Notes | ObjectType-Case Study-2 SourceType-Scholarly Journals-1 ObjectType-Feature-4 content type line 23 ObjectType-Report-1 ObjectType-Article-3 |
| OpenAccessLink | https://doaj.org/article/f263a28c0c824068a64a529aa31ef25c |
| PMID | 34056055 |
| PQID | 2535107619 |
| PQPubID | 23479 |
| PageCount | 4 |
| ParticipantIDs | doaj_primary_oai_doaj_org_article_f263a28c0c824068a64a529aa31ef25c pubmedcentral_primary_oai_pubmedcentral_nih_gov_8149168 proquest_miscellaneous_2535107619 pubmed_primary_34056055 crossref_citationtrail_10_1016_j_jdcr_2021_05_010 crossref_primary_10_1016_j_jdcr_2021_05_010 elsevier_sciencedirect_doi_10_1016_j_jdcr_2021_05_010 elsevier_clinicalkeyesjournals_1_s2_0_S2352512621003465 elsevier_clinicalkey_doi_10_1016_j_jdcr_2021_05_010 |
| PublicationCentury | 2000 |
| PublicationDate | 2021-07-01 |
| PublicationDateYYYYMMDD | 2021-07-01 |
| PublicationDate_xml | – month: 07 year: 2021 text: 2021-07-01 day: 01 |
| PublicationDecade | 2020 |
| PublicationPlace | United States |
| PublicationPlace_xml | – name: United States |
| PublicationTitle | JAAD Case Reports |
| PublicationTitleAlternate | JAAD Case Rep |
| PublicationYear | 2021 |
| Publisher | Elsevier Inc Elsevier |
| Publisher_xml | – name: Elsevier Inc – name: Elsevier |
| References | Kim, Koh (bib8) 2014; 6 Rosenblatt, Stein (bib6) 2015; 33 Stone, Rukasin, Beachkofsky, Phillips (bib7) 2019; 85 Szatkowski, Schwartz (bib9) 2015; 73 Wei, Fishman, Wattenberg, Gordon, Lebwohl (bib3) 2021; 10 Jedlowski, Jedlowski (bib4) 2021; 27 Duong, Valeyrie-Allanore, Wolkenstein, Chosidow (bib5) 2017; 390 Livingston, Malani, Creech (bib1) 2021; 325 Wadman (bib2) 2020; 370 Wadman (10.1016/j.jdcr.2021.05.010_bib2) 2020; 370 Stone (10.1016/j.jdcr.2021.05.010_bib7) 2019; 85 Rosenblatt (10.1016/j.jdcr.2021.05.010_bib6) 2015; 33 Duong (10.1016/j.jdcr.2021.05.010_bib5) 2017; 390 Kim (10.1016/j.jdcr.2021.05.010_bib8) 2014; 6 Szatkowski (10.1016/j.jdcr.2021.05.010_bib9) 2015; 73 Wei (10.1016/j.jdcr.2021.05.010_bib3) 2021; 10 Livingston (10.1016/j.jdcr.2021.05.010_bib1) 2021; 325 Jedlowski (10.1016/j.jdcr.2021.05.010_bib4) 2021; 27 35906789 - J Dermatol. 2022 Dec;49(12):e446-e447 |
| References_xml | – volume: 73 start-page: 843 year: 2015 end-page: 848 ident: bib9 article-title: Acute generalized exanthematous pustulosis (AGEP): a review and update publication-title: J Am Acad Dermatol – volume: 390 start-page: 1996 year: 2017 end-page: 2011 ident: bib5 article-title: Severe cutaneous adverse reactions to drugs publication-title: Lancet – volume: 27 year: 2021 ident: bib4 article-title: Morbilliform rash after administration of Pfizer-BioNTech COVID-19 mRNA vaccine publication-title: Dermatol Online J – volume: 325 start-page: 1575 year: 2021 ident: bib1 article-title: The Johnson & Johnson vaccine for COVID-19 publication-title: JAMA – volume: 6 start-page: 216 year: 2014 end-page: 221 ident: bib8 article-title: Comparison of diagnostic criteria and determination of prognostic factors for drug reaction with eosinophilia and systemic symptoms syndrome publication-title: Allergy Asthma Immunol Res – volume: 10 start-page: 92 year: 2021 end-page: 95 ident: bib3 article-title: ‘COVID arm’: a reaction to the Moderna vaccine publication-title: JAAD Case Rep – volume: 33 start-page: 327 year: 2015 end-page: 332 ident: bib6 article-title: Cutaneous reactions to vaccinations publication-title: Clin Dermatol – volume: 85 start-page: 2694 year: 2019 end-page: 2706 ident: bib7 article-title: Immune-mediated adverse reactions to vaccines publication-title: Br J Clin Pharmacol – volume: 370 start-page: 1022 year: 2020 ident: bib2 article-title: Public needs to prep for vaccine side effects publication-title: Science – volume: 325 start-page: 1575 issue: 15 year: 2021 ident: 10.1016/j.jdcr.2021.05.010_bib1 article-title: The Johnson & Johnson vaccine for COVID-19 publication-title: JAMA doi: 10.1001/jama.2021.2927 – volume: 27 issue: 1 year: 2021 ident: 10.1016/j.jdcr.2021.05.010_bib4 article-title: Morbilliform rash after administration of Pfizer-BioNTech COVID-19 mRNA vaccine publication-title: Dermatol Online J doi: 10.5070/D3271052044 – volume: 33 start-page: 327 issue: 3 year: 2015 ident: 10.1016/j.jdcr.2021.05.010_bib6 article-title: Cutaneous reactions to vaccinations publication-title: Clin Dermatol doi: 10.1016/j.clindermatol.2014.12.009 – volume: 10 start-page: 92 year: 2021 ident: 10.1016/j.jdcr.2021.05.010_bib3 article-title: ‘COVID arm’: a reaction to the Moderna vaccine publication-title: JAAD Case Rep doi: 10.1016/j.jdcr.2021.02.014 – volume: 85 start-page: 2694 issue: 12 year: 2019 ident: 10.1016/j.jdcr.2021.05.010_bib7 article-title: Immune-mediated adverse reactions to vaccines publication-title: Br J Clin Pharmacol doi: 10.1111/bcp.14112 – volume: 370 start-page: 1022 issue: 6520 year: 2020 ident: 10.1016/j.jdcr.2021.05.010_bib2 article-title: Public needs to prep for vaccine side effects publication-title: Science doi: 10.1126/science.370.6520.1022 – volume: 390 start-page: 1996 issue: 10106 year: 2017 ident: 10.1016/j.jdcr.2021.05.010_bib5 article-title: Severe cutaneous adverse reactions to drugs publication-title: Lancet doi: 10.1016/S0140-6736(16)30378-6 – volume: 6 start-page: 216 issue: 3 year: 2014 ident: 10.1016/j.jdcr.2021.05.010_bib8 article-title: Comparison of diagnostic criteria and determination of prognostic factors for drug reaction with eosinophilia and systemic symptoms syndrome publication-title: Allergy Asthma Immunol Res doi: 10.4168/aair.2014.6.3.216 – volume: 73 start-page: 843 issue: 5 year: 2015 ident: 10.1016/j.jdcr.2021.05.010_bib9 article-title: Acute generalized exanthematous pustulosis (AGEP): a review and update publication-title: J Am Acad Dermatol doi: 10.1016/j.jaad.2015.07.017 – reference: 35906789 - J Dermatol. 2022 Dec;49(12):e446-e447 |
| SSID | ssj0001547371 |
| Score | 2.3579242 |
| SourceID | doaj pubmedcentral proquest pubmed crossref elsevier |
| SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 134 |
| SubjectTerms | AGEP Case Report COVID-19 Dermatology DRESS severe adverse cutaneous reaction vaccine |
| Title | A case of severe cutaneous adverse reaction following administration of the Janssen Ad26.COV2.S COVID-19 vaccine |
| URI | https://www.clinicalkey.com/#!/content/1-s2.0-S2352512621003465 https://www.clinicalkey.es/playcontent/1-s2.0-S2352512621003465 https://dx.doi.org/10.1016/j.jdcr.2021.05.010 https://www.ncbi.nlm.nih.gov/pubmed/34056055 https://www.proquest.com/docview/2535107619 https://pubmed.ncbi.nlm.nih.gov/PMC8149168 https://doaj.org/article/f263a28c0c824068a64a529aa31ef25c |
| Volume | 13 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVAON databaseName: DOAJ Directory of Open Access Journals customDbUrl: eissn: 2352-5126 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0001547371 issn: 2352-5126 databaseCode: DOA dateStart: 20150101 isFulltext: true titleUrlDefault: https://www.doaj.org/ providerName: Directory of Open Access Journals – providerCode: PRVHPJ databaseName: ROAD: Directory of Open Access Scholarly Resources customDbUrl: eissn: 2352-5126 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0001547371 issn: 2352-5126 databaseCode: M~E dateStart: 20150101 isFulltext: true titleUrlDefault: https://road.issn.org providerName: ISSN International Centre |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELagQohLxZuUUhmJG0qJn7GP29IKEC1IBbQ3y-uH2KrKVps-bvx2xnGy2gBqL1yyUhxnlJnJzDeb8WeE3hBeO8-DLSmLtoSAZ0urfV1aVlkPUdNZ15G4fq6Pj9V0qr-ubfWVesIyPXBW3LtIJbNUucqplHyUldwKuKVlJEQqXIq-gHrWiqm8PpjXrKu2KCCMErKa7FfM5OauU-8SGSglmbazGmWljrx_lJz-Bp9_9lCuJaXDh2izR5N4kp_iEboTmsfo_lH_vfwJOp9gB2kKLyIGIWEZsLsENBig3Mc2bcUMY4Aau7UNOIJLLK4hlcHQOqNumg0wEX-CrNaGBk88lbv7X37Q3RMMPx_fl0TjK-uSyKfo--HBt_0PZb_HQukEh8pRMckqH2XQ8OqHSsQqCuaI9IFDctfMaw7WIkFyJcAQ3lJbW6L5TDEexCyyZ2ijWTThBcKaK8cF1G9eRi49mc0kF8QFK52k2pMCkUHHxvUE5GkfjDMzdJqdmmQXk-xiKmHALgV6u5pznuk3brx6L5ludWWizu5OgEOZ3qHMbQ5VIDYY3gyrUyGewo3mN4qu_zUrtH1IaA0xLTWVOUkOmfwRau2KcSkKJFYze9ST0cytEl8PXmkgJKTvPNl_DBUMIm36f6pAz7OXrlTCAKBDBQtS65H_jnQ2HmnmPzvacQXFNJFq638o-SV6kB4l9z1vo42L5WV4he65q4t5u9xBd-up2uneaDge_Tr4DcIdTAs |
| linkProvider | Directory of Open Access Journals |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=A+case+of+severe+cutaneous+adverse+reaction+following+administration+of+the+Janssen+Ad26.COV2.S+COVID-19+vaccine&rft.jtitle=JAAD+Case+Reports&rft.au=Kristen+Lospinoso%2C+BS&rft.au=Cameron+S.+Nichols%2C+MD&rft.au=Stephen+J.+Malachowski%2C+MD&rft.au=Mark+C.+Mochel%2C+MD&rft.date=2021-07-01&rft.pub=Elsevier&rft.issn=2352-5126&rft.eissn=2352-5126&rft.volume=13&rft.spage=134&rft.epage=137&rft_id=info:doi/10.1016%2Fj.jdcr.2021.05.010&rft.externalDBID=DOA&rft.externalDocID=oai_doaj_org_article_f263a28c0c824068a64a529aa31ef25c |
| thumbnail_m | http://cvtisr.summon.serialssolutions.com/2.0.0/image/custom?url=https%3A%2F%2Fcdn.clinicalkey.com%2Fck-thumbnails%2F23525126%2Fcov200h.gif |